We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

QuantumSi Inc

Company price
1.1707 USD -0.10 ( 7.82%)
Last update at 2026-11-12T15:22:00Z
VOLUME
1078202
Market Cap
157.60M

Momentum Score

…

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.16
Low
1.21
High
52 Week Price Range
0.69
Low
3.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.27
Dividend Yield
-
Revenue TTM
1.60M
Revenue Per Share
0.01
Gross Profit TTM
0.56M
Debt / Equity
0.02
ROE
-49.11%
Net Debt
-17.47M
ROCE
-43.74%
Diluted EPS TTM
-0.46

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -101.28M -100.95M -95.96M -132.44M -94.99M
Net income -101.34M -101.01M -95.96M -141.04M -88.95M
Selling general administrative 44.75M 50.53M 42.81M 42.30M 46.38M
Selling and marketing expenses - - 0.40M - 3.96M
Gross profit 1.15M 1.60M 0.49M - -
Reconciled depreciation 4.45M 4.60M 3.86M 2.58M 1.04M
Ebit -97.36M -100.95M -95.96M -123.84M -96.91M
Ebitda -92.91M -96.35M -91.80M -134.50M -101.91M
Depreciation and amortization 4.45M 4.60M 4.16M -10.66M -5.00M
Non operating income net other - - - -8.60M 1.92M
Operating income -97.36M -108.58M -111.17M -123.84M -96.91M
Other operating expenses 99.80M 111.63M 112.25M 114.36M 96.91M
Interest expense - - 0.00M 13.25M 0.01M
Tax provision 0.06M 0.06M 0.00M 0.00M 0.00M
Interest income 8.96M 9.64M 0.46M - -
Net interest income 8.96M 9.64M 0.46M 0.00M -0.01M
Non recurring - - - 9.48M -
Income tax expense 0.06M 0.06M 0.00M 8.60M -6.04M
Total revenue 2.44M 3.06M 1.08M 0.00M 0.00M
Total operating expenses 98.51M 110.18M 111.66M 114.36M 96.91M
Cost of revenue 1.28M 1.46M 0.59M - -
Total other income expense net -3.92M 7.62M 15.21M -8.60M 1.92M
Net income from continuing ops -101.34M -101.01M -107.05M -132.44M -94.99M
Net income applicable to common shares - - - -132.44M -94.99M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 245.61M 247.87M 298.25M 391.49M 503.23M
Intangible assets - - 0.53M - -
Other current assets 9.19M 3.01M 4.26M 6.87M 5.87M
Total liab 25.38M 32.45M 26.63M 32.78M 26.19M
Total stockholder equity 220.23M 215.42M 271.62M 358.71M 477.03M
Deferred long term liab - - - 1.00M 7.24M
Other current liab 16.07M 11.22M 6.76M 10.43M 0.02M
Common stock 0.02M 0.02M 0.01M 0.01M 0.01M
Capital stock 0.02M 0.02M 0.01M 0.01M 0.01M
Retained earnings -697.98M -596.64M -495.63M -399.67M -267.23M
Other liab - - - 1.00M 7.45M
Good will - - - 0.00M 9.48M
Other assets - - 0.00M 0.70M 0.69M
Cash 21.64M 49.24M 133.86M 84.32M 35.78M
Total current liabilities 23.02M 18.19M 11.61M 15.71M 11.53M
Current deferred revenue 3.49M - 1.52M - 7.25M
Net debt -17.47M -36.29M -118.56M -66.87M -27.71M
Short term debt 1.84M 3.70M 1.57M 1.37M 0.86M
Short long term debt total 4.17M 12.95M 15.30M 17.45M 8.08M
Other stockholder equity 918.19M 812.00M 767.24M 758.37M 744.25M
Property plant equipment - - - 16.85M 15.88M
Total current assets 175.86M 218.01M 266.31M 358.18M 477.17M
Long term investments 52.85M 0.00M - - -
Net tangible assets - - - 358.71M 467.55M
Short term investments 141.27M 160.36M 123.88M 266.99M 435.52M
Net receivables 0.56M 1.33M 0.37M 0.21M 0.87M
Inventory 3.20M 4.07M 3.94M - -
Accounts payable 1.62M 1.93M 1.77M 3.90M 3.39M
Accumulated other comprehensive income -0.01M 0.04M - - -503.23M
Common stock total equity - - - 0.01M 0.01M
Retained earnings total equity - - - -399.67M -267.23M
Non currrent assets other 0.23M 0.81M 0.69M 0.70M 0.69M
Non current assets total 69.75M 29.86M 31.94M 33.30M 26.05M
Capital lease obligations 4.17M 12.95M 15.30M 17.45M 8.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -25.80M -32.67M 107.86M 147.93M -440.54M
Change to liabilities - - - 4.73M 5.21M
Total cashflows from investing activities -28.32M -32.67M 143.43M 137.19M -450.94M
Net borrowings - - 0.00M - -1.75M
Total cash from financing activities 95.42M 35.88M 0.15M 1.91M 516.62M
Change to operating activities - - - 3.58M 0.76M
Net income -101.34M -101.01M -95.96M -132.44M -94.99M
Change in cash -27.60M -84.62M 49.54M 48.53M -1.12M
Begin period cash flow 49.24M 133.86M 84.32M 35.78M 36.91M
End period cash flow 21.64M 49.24M 133.86M 84.32M 35.78M
Total cash from operating activities -94.72M -87.80M -94.04M -90.56M -66.81M
Issuance of capital stock 93.51M 34.79M 0.00M 0.00M 512.79M
Depreciation 4.45M 4.60M 4.16M 2.58M 1.04M
Other cashflows from investing activities - -0.06M -0.76M - -4.63M
Change to inventory -2.01M 4.34M 0.29M - -
Change to account receivables 0.63M -1.09M -0.37M - -
Sale purchase of stock - - - 2.76M 5.61M
Other cashflows from financing activities 0.00M 1.09M 0.15M -0.85M 5.61M
Change to netincome - - - 14.71M 25.67M
Capital expenditures 2.52M 4.58M 5.27M 10.74M 5.76M
Cash flows other operating - - - 19.86M -3.74M
Cash and cash equivalents changes - - - 48.53M -1.12M
Change in working capital -4.58M 4.64M -3.19M 4.30M 1.47M
Stock based compensation 10.77M 8.89M 8.52M 11.21M 24.92M
Other non cash items -4.03M -4.92M -7.55M 23.79M 0.04M
Free cash flow -97.23M -92.38M -99.31M -101.30M -72.58M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
QSI
QuantumSi Inc
-0.10
7.82%
1.17 - - 98.19 0.88 31.28 0.63
ABT
Abbott Laboratories
-0.71
0.65%
108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
0.28
0.28%
101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-2.16
0.68%
316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

QuantumSi Inc

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

29 Business Park Drive, Branford, CT, United States, 06405

866 688 7374

145

Name Title Year Born
Dr. Jonathan M. Rothberg Ph.D. Founder & Exec. Chairman 1964
Ms. Claudia Napal Drayton Chief Financial Officer 1968
Dr. Christian Lapointe J.D., Ph.D. Gen. Counsel & Corp. Sec. 1972
Dr. Michael P. McKenna Ph.D. Exec. VP of Product Devel. & Operations 1962
Mr. Jeffrey Alan Hawkins CEO & Director 1978
Dr. Patrick Schneider Ph.D. Pres & COO NA
Mr. Todd Rearick Chief Technology Officer NA
Mr. Juan Esteban Avendano VP of Investor Relations NA
Dr. Jonathan M. Rothberg Ph.D. Founder & Executive Chairman 1964
Mr. Jeffrey Alan Hawkins President, CEO & Director 1978

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…